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Introduction
Topic
•

•

•

•

•

Pheochromocytomas are tumors of
the endocrine system, otherwise
known as paragangliomas that
affect the adrenal medulla (Azadeh,
Ramakrishna, Bhatia, Charles, &
Mookadam, 2015).
Wu et al. (2018, p. 1) defines
pheochromocytoma as “a tumor
deriving from adrenomedullary
chromaffin cells that produces one
or more catecholamines:
epinephrine, norepinephrine, and
dopamine”.
This tumor produces
catecholamines such as
epinephrine and norepinephrine,
and can be lethal if un-treated
(Azadeh et al., 2015).
Between 1.5-2.1 million individuals
will be affected with the disease
and the disease affects 0.1% of the
high blood pressure population
(Sonntagbauer, Koch, Strouhal,
Zacharowski, & Weber, 2018);
(Aksakal et al., 2018).
Pheochromocytoma’s diagnosis
depends on the clinician’s
knowledge of the condition
combined with computerized
tomography (CT) scanning (MulaAbed et al., 2015) (See Figure 1).

Signs and Symptoms
•

•

•

•

•

•

Clinical Relevance
•

•

•

The importance of proper
assessment and diagnosis of
individuals with symptomology
suggesting pheochromocytoma is
paramount.
The clinical relevance is due to
there being a definite risk of
undergoing general
anesthesia/surgical procedure
when afflicted with this disease,
since, according to Azadeh et al.,
(2015), patients with undiagnosed
pheochromocytoma, while under
the effects of anesthesia, may have
a fatal hypertensive crisis.
There are specific interventions to
take as the anesthetist when
pheochromocytoma removal is
proposed (Sonntagbauer et al.,
2018).

During perioperative management,
it is important to manage
symptomology that the patient may
experience such as hyperglycemia
or fever (Azadeh et al., 2015).
Common symptoms of the disease
can also include include headache,
sweating, fluttering in chest, and
high blood pressure (Mula-Abed et
al., 2015).
Pheochromocytoma may exhibit
primarily with external symptoms
of tachyarrhythmias, hypertension,
sweating, and headache (Aksakal et
al., 2018).
Langton et al., (2018) proposes
immense risk for the pregnant
mother and her unborn baby
throughout antepartum due to
possibility of tachycardia and
malignant hypertension
Wu et al., (2018) studies a case
report of a teenager with
pheochromocytoma presenting to
the emergency department with
tachycardia, hypotension, hypoxia,
and cough with hemoptysis. This
patient also presented with
takotsubo cardiomyopathy,
diastolic heart failure, upper
respiratory tract infection, and
acute liver dysfunction.
Some patients may only have
abdominal pain with concurrent
distention of the abdomen (Afaneh,
Yang, Hamza, Schervish, & Berri,
2017).

Pathophysiology
•

•

•

•

Angelousi, Kassi, Zografos, and
Kaltsas (2015) associate “genetic
alterations of these genes with
transcriptome changes” and divide
pheochromocytoma into two
clusters of genetic disorders
(Angelousi, Kassi, Zografos, &
Kaltsas, 2015, p. 987).
Pheochromocytomas are very
vascularized, making the patient
potentially hemodynamically
unstable even if early intervention
occurs (Aksakal et al., 2018) (See
figure 2).
Individuals who have
pheochromocytoma that go
undiagnosed may develop
catecholamine crisis, which is a life
threatening increase in circulating
catecholamines. This can cause
dangerous cardiovascular
dysrhythmias and contribute to
death (Sonntagbauer et al., 2018).
One way to diagnose the disease is
by a metabolized 24-hour urine test
that analyzes the urine for
catecholamine metabolites. Another
test that is more commonly used is
the analysis of fractioned
catecholamines in the patient’s
plasma (Mula-Abed et al., 2015).

Implications for
Anesthesia Care
•

•

•

Special consideration should be
regarded to those with known
diagnosis of pheochromocytoma or
those undergoing tumor excision via
en bloc resection or adrenalectomy
(Aksakal et al., 2018).
If patients develop hypotension
during the case, crystalloid infusion
is indicated first, followed by
dopamine after excision of the
tumor (Aksakal et al., 2018).
Sonntagbauer et al., (2018) states
that propofol may stimulate the
sympathetic nervous system due to
injection pain. Fentanyl, under
certain doses, may elicit a positive
inotropic effect. Rocuronium, on the
other hand, influences atrial tissue
by stimulating norepinephrine
release along with stimulation of
beta-1 receptors.

Conclusion

Treatment
•

•
•
•

•

•

According to Azadeh et al., (2015), the adrenergic receptors throughout the body
are typically sensitized to the high level of circulating catecholamines and can
cause hypotension and/or hypertension. Patients are generally started on high
volumes of crystalloid infusions to prevent hypotension. The preferred
pharmacological management of the patient involves alpha-blockers, betablockers, and calcium channel blockers to maintain normotension and normal
resting heart rate. The preferred alpha blocker to achieve normotension is
phenoxybenzamine. Secondly, after successful alpha blockade has been initiated,
beta-blockers are to be started on a case by case basis. Calcium channel blockers
can also be used to prevent coronary artery vasospasm or unintended
tachydysrhythmias. “In this situation calcium channel blockers can be used as an
adjunct to help control vasospasm as well as tachyarrhythmias” (Azadeh et al.,
2015).
If the tumor is diagnosed in its infancy, simple laparoscopic technique may be
indicated (Mula-Abed et al., 2015).
En bloc technique may also be indicated, with the five year survival rate of over 90
percent if the tumor is benign (Aksakal et al., 2018).
Complicated cases, possibly related to tumor size, or surgeon preference, may elicit
the patient to undergo adrenalectomy to reduce risk of excess catecholamine
secretion during surgery (Chung et al., 2018) (See figure 3).
The role of the anesthetist is to prevent concurrent hemodynamic instability
throughout the case and to assure that pre-operative medications were
administered appropriately and in the correct timeframe (Wolf et al., 2019) (See
figure 4).
Special consideration is to be undertaken when tumor size is <6cm in diameter
along with urinary catecholamine values higher than the maximum value of 2000
ug/24 hour period (Aksakal et al., 2018).

•
•

•

•

•

Pheochromocytoma presents with
unusual symptomology and can
remain difficult to diagnose.
Early detection is paramount along
with pre-surgical pharmacological
intervention for best outcomes.
Decrease manipulation of tumor to
avoid additional secretion of
catecholamine (Chung et al., 2018).
From an anesthesia perspective,
pheochromocytomas in patients
presents a severe risk to the
preservation of life pre, intra, and
post-operatively.
It remains necessary to prevent
hemodynamic instability and to
prevent administration of drugs
which may elicit hemodynamic
instability, since prolonged
hemodynamic instability may lead
to loss of life or chronic disability
(Sonntagbauer et al., 2018).
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